Favorable Event Free-Survival of High-Dose Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation for Higher Risk Diffuse Large B-Cell Lymphoma in First Complete Remission

High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) has been applied to patients with diffuse large Bcell lymphoma (DLBCL); it is well established that ASCT shows significant survival benefits for chemosensitive relapse. However, half of relapsed patients are resistant to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hematol Rep
Main Authors: Kaneko, Hiroto, Tsutsumi, Yasuhiko, Fujino, Takahiro, Kuwahara, Saeko, Ohshiro, Muneo, Iwai, Toshiki, Kuroda, Junya, Yokota, Shouhei, Horiike, Shigeo, Taniwaki, Masafumi
Formato: Artigo
Idioma:Inglês
Publicado: PAGEPress Publications, Pavia, Italy 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4508550/
https://ncbi.nlm.nih.gov/pubmed/26330999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2015.5812
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares